# The Effect of Intravenous Lipids on Lung Function in Acute Respiratory Distress Syndrome (ARDS)

> **NCT01096771** · PHASE2 · TERMINATED · sponsor: **Methodist Research Institute, Indianapolis** · enrollment: 14 (actual)

## Conditions studied

- Acute Respiratory Distress Syndrome

## Interventions

- **DRUG:** ClinOleic 20%
- **DRUG:** Intralipid 20%

## Key facts

- **NCT ID:** NCT01096771
- **Lead sponsor:** Methodist Research Institute, Indianapolis
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-06
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Unable to secure product from international source, low recruitment rate.
- **Last updated:** 2014-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01096771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01096771, "The Effect of Intravenous Lipids on Lung Function in Acute Respiratory Distress Syndrome (ARDS)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01096771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*